This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Sildenafil citrate (oral therapy)

Authoring team

This is an oral therapy that has a UK license for erectile dysfunction.

It is a phosphodiesterase 5 (PDE5) inhibitor which in turn enhances the effect of nitric oxide. Nitric oxide acts on enzymes which enable smooth-muscle relaxation in the corpus cavernosum, allowing an inflow of blood, and resulting in a penile erection.

Sildenafil citrate is contra-indicated in patients taking organic nitrates (1).

Reported side effects include flushing, headache, dyspepsia, nasal congestion, dizziness, diarrhoea, rashes and UTIs. There have been six reports of deaths (related to MIs) occurring in users of sildenafil citrate. It is unclear whether sildenafil citrate reacted with prescribed heart medication or the deaths were the result of unaccustomed sexual exertion.

Ref:Bandolier (1998), 5(7),1-4.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.